Key result
Amiodarone effectively reduces excitability and slows conduction in Wolff-Parkinson-White syndrome, offering an alternative to surgery despite its high incidence of side effects and long half-life.
Why the study?
Does amiodarone improve management of Wolff-Parkinson-White syndrome?
Population
Patients with Wolff-Parkinson-White (WPW) syndrome
Design
Review
Authors
Loading...
Amiodarone may be considered in select WPW cases; leaves open need for modern trials versus ablation given side-effect risks.
Does amiodarone improve management of Wolff-Parkinson-White syndrome?
Amiodarone is an effective alternative to surgery for WPW syndrome, though its use requires caution due to significant side effects and a long half-life.
Lukas Kappenberger (1986) conducted a review in Wolff-Parkinson-White Syndrome. Amiodarone was evaluated. Amiodarone effectively reduces excitability and slows conduction in Wolff-Parkinson-White syndrome, offering an alternative to surgery despite its high incidence of side effects and long half-life.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: